Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 01, 2007 (Vol. 27, No. 3)

Outsourcing Phase IV Pharma Research

  • According to a new report by Cutting Edge Information (www.cuttingedgeinfo.com), 42.6% of companies that have the internal infrastructure in place to manage Phase IV studies in-house still choose to outsource much of the work associated with their post-marketing studies. The report, “Phase IV Clinical Trials: Post-Marketing Study Management Structure, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.